Capital Wealth Planning’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.4M | Buy |
57,056
+21,238
| +59% | +$4.71M | 0.07% | 81 |
|
|
2025
Q4 | $8.18M | Buy |
+35,818
| New | +$8.16M | 0.05% | 77 |
|
|
2025
Q2 | – | Sell |
-6,609
| Closed | -$1.38M | – | 142 |
|
|
2025
Q1 | $1.38M | Sell |
6,609
-126
| -2% | -$24.5K | 0.01% | 92 |
|
|
2024
Q4 | $1.2M | Sell |
6,735
-235
| -3% | -$43.2K | 0.01% | 91 |
|
|
2024
Q3 | $1.38M | Sell |
6,970
-1,512
| -18% | -$282K | 0.01% | 87 |
|
|
2024
Q2 | $1.45M | Sell |
8,482
-1,132
| -12% | -$188K | 0.02% | 86 |
|
|
2024
Q1 | $1.75M | Buy |
+9,614
| New | +$1.66M | 0.02% | 72 |
|
|
2023
Q4 | – | Sell |
-2,022
| Closed | -$301K | – | 139 |
|
|
2023
Q3 | $301K | Buy |
+2,022
| New | +$297K | ﹤0.01% | 124 |
|
|
2022
Q2 | – | Sell |
-1,259
| Closed | -$204K | – | 79 |
|
|
2022
Q1 | $204K | Buy |
+1,259
| New | +$183K | ﹤0.01% | 89 |
|
|
2021
Q4 | – | Sell |
-2,287
| Closed | -$247K | – | 105 |
|
|
2021
Q3 | $247K | Sell |
2,287
-828
| -27% | -$94.6K | 0.01% | 97 |
|
|
2021
Q2 | $351K | Sell |
3,115
-324
| -9% | -$36.5K | 0.01% | 87 |
|
|
2021
Q1 | $372K | Sell |
3,439
-617
| -15% | -$66K | 0.01% | 79 |
|
|
2020
Q4 | $450K | Sell |
4,056
-3,312
| -45% | -$318K | 0.02% | 69 |
|
|
2020
Q3 | $645K | Sell |
7,368
-959
| -12% | -$90.3K | 0.03% | 60 |
|
|
2020
Q2 | $818K | Sell |
8,327
-4,090
| -33% | -$360K | 0.05% | 55 |
|
|
2020
Q1 | $946K | Buy |
12,417
+4,789
| +63% | +$408K | 0.06% | 81 |
|
|
2019
Q4 | $675K | Sell |
7,628
-2,382
| -24% | -$198K | 0.04% | 107 |
|
|
2019
Q3 | $769K | Buy |
10,010
+1,864
| +23% | +$128K | 0.05% | 106 |
|
|
2019
Q2 | $592K | Buy |
+8,146
| New | +$640K | 0.04% | 119 |
|
|
2015
Q3 | – | Sell |
-9,628
| Closed | -$647K | – | 104 |
|
|
2015
Q2 | $647K | Sell |
9,628
-10,914
| -53% | -$713K | 0.39% | 52 |
|
|
2015
Q1 | $1.2M | Hold |
20,542
| – | – | 0.63% | 39 |
|
|
2014
Q4 | $1.34M | Sell |
20,542
-2,500
| -11% | -$158K | 0.63% | 35 |
|
|
2014
Q3 | $1.33M | Buy |
23,042
+3,514
| +18% | +$195K | 0.54% | 38 |
|
|
2014
Q2 | $1.1M | Buy |
19,528
+9,900
| +103% | +$519K | 0.41% | 48 |
|
|
2014
Q1 | $495K | Sell |
9,628
-29,372
| -75% | -$1.48M | 0.21% | 73 |
|
|
2013
Q4 | $1.59M | Buy |
39,000
+15,372
| +65% | +$756K | 1.92% | 12 |
|
|
2013
Q3 | $1.06M | Sell |
23,628
-15,372
| -39% | -$681K | 0.48% | 38 |
|
|
2013
Q2 | $1.61M | Buy |
+39,000
| New | +$1.71M | 1.27% | 20 |
|
Other funds holding ABBV
VCM
VPM
Capital Wealth Planning's ABBV Position: Q1 2026 in Review
Capital Wealth Planning increased its AbbVie (ABBV) stake by 59% in Q1 2026, buying an estimated $4.71M and bringing the position to 57,056 shares worth $12.4M. The position accounts for 0.07% of the portfolio, ranked #81.
Capital Wealth Planning first reported a position in ABBV in Q2 2013 and has held it in 28 quarters since. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Capital Wealth Planning held 57,056 shares of AbbVie worth $12.4M as of Q1 2026.
- Capital Wealth Planning bought 21,238 AbbVie shares in Q1 2026, an estimated $4.71M.
- AbbVie made up 0.07% of Capital Wealth Planning's portfolio in Q1 2026, its #81 holding.
- Capital Wealth Planning first reported a position in AbbVie in Q2 2013 and has held it in 28 quarters since.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Capital Wealth Planning's 13F filing for Q1 2026, filed 15 May 2026.